Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,876 papers from all fields of science
Search
Sign In
Create Free Account
Cryptococcus neoformans Ab:Titr:Pt:Ser:Qn:Aggl
Known as:
Cryptococcus neoformans As:Titer:Moment:Serum:Kwantitatief:Agglutinatie
, Cryptococcus neoformans Ac [Titre] Sérum ; Numérique ; Agglutination
, Cryptococcus neoformans Antibody:Dilution Factor (Titer):Point in time:Serum:Quantitative:Agglutination
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
7 relations
Aggl
Antibodies
Cryptococcus
Cryptococcus neoformans
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on Melanized and Non-melanized Cryptococcus neoformans
Orionalda de Fátima Lisboa Fernandes
,
C. R. Costa
,
+4 authors
Maria do Rosário Rodrigues Silva
Mycopathologia
2012
Corpus ID: 254868239
In the present study, the in vitro susceptibility and capsular width from both melanized and non-melanized Cryptococcus…
Expand
2011
2011
Synthesis of Aryl Aldimines and Their Activity against Fungi of Clinical Interest
C. M. da Silva
,
D. L. da Silva
,
+7 authors
Â. de Fátima
Chemical Biology and Drug Design
2011
Corpus ID: 30743467
Aldimines are aldehyde‐derived compounds that contain a C=N group. Besides its broad industrial applications, this class of non…
Expand
2011
2011
The Effect of Capsular Size of C. neoformans on Pathogenicity and Pathological Changes in Experimentally Infected Mice
Kawkab A.Ahmed
,
Heidy Abo El Yazeed
,
H. Kotb
,
Mona Elshabrawy
,
R. Alarousy
,
M. Refai
2011
Corpus ID: 90305324
The present work was carried out to study the correlation of capsular size and pathogenicity of C. neoformans in experimentally…
Expand
2009
2009
The Cryptococcus neoformans cap10 and cap59 mutant strains, affected in glucuronoxylomannan synthesis, differentially activate human dendritic cells.
J. Grijpstra
,
Boris Tefsen
,
I. van Die
,
H. de Cock
FEMS Immunology & Medical Microbiology
2009
Corpus ID: 161690
The human pathogen Cryptococcus neoformans causes meningo-encephalitis. The polysaccharide capsule is one of the main virulence…
Expand
2007
2007
Studies of the structures, biosynthesis and function of fungal glycosphingolipids
E. Owuor
2007
Corpus ID: 73559420
STUDIES OF THE STRUCTURES, BIOSYNTHESIS AND FUNCTION OF FUNGAL GLYCOSPHINGOLIPIDS by Elizabeth A. Owuor University of New…
Expand
2005
2005
Electrophoretic karyotypes of C. neoformans serotype A recovered from Thai Patients with AIDS
P. Ngamwongsatit
,
S. Sukroongreung
,
C. Nilakul
,
V. Prachayasittikul
,
S. Tantimavanich
Mycopathologia
2005
Corpus ID: 35414923
Thirty-seven clinical isolates of C. neoformans were recovered from AIDS patients and all were serotype A according to standard…
Expand
2004
2004
In vivo interaction between alveolar macrophages and Cryptococcus neoformans
K. Nessa
,
N. Gross
,
C. Jarstrand
,
A. Johansson
,
P. Camner
Mycopathologia
2004
Corpus ID: 23487572
In vivo interactions of rabbit alveolar macrophages (AM) and Cryptococcus neoformans, a yeast pathogenic for humans, were studied…
Expand
Highly Cited
1998
Highly Cited
1998
Antigen-Induced Protective and Nonprotective Cell-Mediated Immune Components against Cryptococcus neoformans
J. W. Murphy
,
F. Schafer
,
A. Casadevall
,
A. Adesina
Infection and Immunity
1998
Corpus ID: 43186232
ABSTRACT Mice immunized with two different cryptococcal antigen preparations, one a soluble culture filtrate antigen (CneF) in…
Expand
1970
1970
Small tissue forms (microforms) of C. neoformans.
G. Bader
,
B. Busch
1970
Corpus ID: 84047269
1950
1950
[Capsular polyoside of a pathogenic fungus Torulopsis neoformans; relation to virulence].
E. Drouhet
,
G. Ségretain
,
J. Aubert
Annales de l'Institut Pasteur
1950
Corpus ID: 30252550
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE